Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,247 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I/II trial of cure-oriented high-dose chemoradiotherapy with transplantation of CD34+ peripheral blood stem cells purified by the immunomagnetic bead method for refractory hematological malignancies. Nagoya CD34+ PBSCT Study Group.
Ogura M, Kagami Y, Suzuki R, Miura K, Uehira K, Kurokawa T, Ito T, Kinoshita T, Emi N, Morishima Y, Kodera Y, Ueda R. Ogura M, et al. Cancer Chemother Pharmacol. 1997;40 Suppl:S51-7. doi: 10.1007/s002800051062. Cancer Chemother Pharmacol. 1997. PMID: 9272135 Clinical Trial.
Assessment of prognostic factors in follicular lymphoma patients.
Kondo E, Ogura M, Kagami Y, Taji H, Miura K, Takeuchi T, Maeda S, Asakura S, Suzuki R, Nakamura S, Morishima Y. Kondo E, et al. Among authors: ogura m. Int J Hematol. 2001 Apr;73(3):363-8. doi: 10.1007/BF02981963. Int J Hematol. 2001. PMID: 11345204
Re-treatment of relapsed indolent B-cell lymphoma with rituximab.
Igarashi T, Ohtsu T, Fujii H, Sasaki Y, Morishima Y, Ogura M, Kagami Y, Kinoshita T, Kasai M, Kiyama Y, Kobayashi Y, Tobinai K; IDEC-C2B8 Study Group. Igarashi T, et al. Among authors: ogura m. Int J Hematol. 2001 Feb;73(2):213-21. doi: 10.1007/BF02981940. Int J Hematol. 2001. PMID: 11372734 Clinical Trial.
CD34+-selected autologous peripheral blood stem cell transplantation conditioned with total body irradiation for malignant lymphoma: increased risk of infectious complications.
Maeda S, Kagami Y, Ogura M, Taji H, Suzuki R, Kondo E, Asakura S, Takeuchi T, Miura K, Ando M, Nakamura S, Ito T, Kinoshita T, Ueda R, Morishima Y. Maeda S, et al. Among authors: ogura m. Int J Hematol. 2001 Aug;74(2):214-21. doi: 10.1007/BF02982008. Int J Hematol. 2001. PMID: 11594525 Clinical Trial.
1,247 results